Johnson & Johnson to buy Swiss drug maker Actelion for $30B
Thursday, January 26, 2017 - 11:31
in Mathematics & Economics
Eric DuVallJan. 26 (UPI) -- U.S. pharmaceutical company Johnson & Johnson has agreed to purchase Swiss competitor Actelion for $30 billion in cash, the companies announced Thursday.